Activities, Bill Numbers and Titles
|
|
Client: Pharmaceutical Research and Manufacturers of America Corporation
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $3,446.91
|
House Bill
|
5159
|
An Act enhancing the market review process
|
Support
|
$0.00
|
N/A
|
House Bill
|
3012
|
An Act relative to pharmaceutical access, costs and transparency
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
2881
|
An Act enhancing the health care market review process
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
5100
|
An Act relative to strengthening Massachusetts’ economic leadership
|
Support
|
$0.00
|
N/A
|
House Bill
|
4891
|
An Act promoting access and affordability of prescription drugs
|
Support
|
$0.00
|
N/A
|
House Bill
|
4910
|
An Act promoting access and affordability of prescription drugs
|
Support
|
$0.00
|
N/A
|
House Bill
|
4653
|
An Act enhancing the market review process
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
2520
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
No campaign contributions were filed for this disclosure reporting period. |
|